Advisory Services Network’s Edesa Biotech EDSA Stock Holding History

Advisory Services Network’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3	Closed	-$1K	–	2518
2018 Q1	$1K	Hold	3	–	–	﹤0.01%	2462
2017 Q4	$1K	Hold	3	–	–	﹤0.01%	2438
2017 Q3	$1K	Hold	3	–	–	﹤0.01%	2259
2017 Q2	$1K	Hold	3	–	–	﹤0.01%	2204
2017 Q1	$1K	Buy	+3	New	+$1.59K	﹤0.01%	2066
2016 Q3	$2K	Hold	3	–	–	﹤0.01%	1773
2016 Q2	$3K	Hold	3	–	–	﹤0.01%	1547
2016 Q1	$4K	Buy	+3	New	+$5.25K	﹤0.01%	1314

Other funds holding EDSA

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Advisory Services Network's EDSA Position: Q2 2018 in Review

Advisory Services Network sold out of Edesa Biotech (EDSA) in Q2 2018, closing a stake of 3 shares — an estimated $1K sold.

Advisory Services Network first reported a position in EDSA in Q1 2016 and held it in 8 quarters. The position peaked at $4K in Q1 2016. 10 funds tracked by Wall St. Rank hold EDSA as of Q2 2018.

Advisory Services Network reported no remaining Edesa Biotech position as of Q2 2018 after selling out during the quarter.
Advisory Services Network sold 3 Edesa Biotech shares in Q2 2018, an estimated $1K.
Advisory Services Network first reported a position in Edesa Biotech in Q1 2016 and held it in 8 quarters.
Advisory Services Network's Edesa Biotech position peaked at $4K in Q1 2016.
10 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2018.

Based on Advisory Services Network's 13F filing for Q2 2018, filed 27 Jul 2018.